• Explore /
  • Poster
  • / Optimization of Voyager V1 (VV1) oncolytic virus systemic delivery in combination with cemiplimab and ipilimumab in patients with melanoma and non–small cell lung cancer (NSCLC).

Optimization of Voyager V1 (VV1) oncolytic virus systemic delivery in combination with cemiplimab and ipilimumab in patients with melanoma and non–small cell lung cancer (NSCLC).

Abstract Video & Slides Poster

Authors

Jose Lutzky

Jose Lutzky

University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

Jose Lutzky , Thomas Urban Marron , Steven Francis Powell , Daniel H. Johnson , Manish Patel , Anthony B. El-Khoueiry , John Sarantopoulos , Saida Dadi-Mehmetaj , Luke Russell , Stephen J. Russell , Kah Whye Peng , Stephen Kaesshaefer , Giuseppe Gullo , Alice Susannah Bexon , Mario Sznol

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT04291105

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS9595)

DOI

10.1200/JCO.2022.40.16_suppl.TPS9595

Abstract #

TPS9595

Poster Bd #

186a

Abstract Disclosures

Similar Posters

First Author: Robin Kate Kelley

First Author: Ahmad A. Tarhini

First Author: Martin Reck

First Author: Benjamin Besse